Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Werner Vach

Showing results (1-10 of 297) with videos related to

Pageof 30
Sort By:
Journal of Clinical Epidemiology|December 15, 2025
Comment on "In humble defense of unexplainable black box prediction models in healthcare"Werner Vach
Diagnostic and Prognostic Research|November 4, 2025
Targeted test evaluation: five suggestions for refining the framework for designing diagnostic accuracy studies with clear study hypothesesWerner Vach
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|February 21, 2014
[Quantifying the additional clinical benefit of new medicines: little - considerable - significant - 6 remarks from a biometrician's point of view]Werner Vach
Biometrical Journal. Biometrische Zeitschrift|August 28, 2007
Regarding paper "Five interval estimators for proportion ratio under a stratified randomized clinical trial with noncompliance" by Lui K. J. and Chang K. CWerner Vach
Journal of Clinical Epidemiology|June 9, 2005
The dependence of Cohen's kappa on the prevalence does not matterWerner Vach
Journal of Clinical Epidemiology|September 12, 2013
Calibration of clinical prediction rules does not just assess biasWerner Vach
Journal of Clinical Epidemiology|May 4, 2026
Conditions for unbiased estimation of sensitivity and specificity when using a probabilistic reference standard could be identifiedWerner Vach
Diagnostic and Prognostic Research|May 17, 2019
Value-based and benefit-based strategies in deciding to bring a test into use should be distinguishedWerner Vach
BMC Medical Research Methodology|August 3, 2019
Constructing treatment selection rules based on an estimated treatment effect function: different approaches to take stochastic uncertainty into account have a substantial effect on performanceMaren Eckert, Werner Vach
Journal of Biopharmaceutical Statistics|June 5, 2015
A framework to assess the value of subgroup analyses when the overall treatment effect is significantHong Sun, Werner Vach
Pageof 30

Showing results (1-10 of 297) with videos related to

Sort By:
Pageof 30
Journal of Clinical Epidemiology|December 15, 2025
Comment on "In humble defense of unexplainable black box prediction models in healthcare"Werner Vach
Diagnostic and Prognostic Research|November 4, 2025
Targeted test evaluation: five suggestions for refining the framework for designing diagnostic accuracy studies with clear study hypothesesWerner Vach
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|February 21, 2014
[Quantifying the additional clinical benefit of new medicines: little - considerable - significant - 6 remarks from a biometrician's point of view]Werner Vach
Biometrical Journal. Biometrische Zeitschrift|August 28, 2007
Regarding paper "Five interval estimators for proportion ratio under a stratified randomized clinical trial with noncompliance" by Lui K. J. and Chang K. CWerner Vach
Journal of Clinical Epidemiology|June 9, 2005
The dependence of Cohen's kappa on the prevalence does not matterWerner Vach
Journal of Clinical Epidemiology|September 12, 2013
Calibration of clinical prediction rules does not just assess biasWerner Vach
Journal of Clinical Epidemiology|May 4, 2026
Conditions for unbiased estimation of sensitivity and specificity when using a probabilistic reference standard could be identifiedWerner Vach
Diagnostic and Prognostic Research|May 17, 2019
Value-based and benefit-based strategies in deciding to bring a test into use should be distinguishedWerner Vach
BMC Medical Research Methodology|August 3, 2019
Constructing treatment selection rules based on an estimated treatment effect function: different approaches to take stochastic uncertainty into account have a substantial effect on performanceMaren Eckert, Werner Vach
Journal of Biopharmaceutical Statistics|June 5, 2015
A framework to assess the value of subgroup analyses when the overall treatment effect is significantHong Sun, Werner Vach
Pageof 30